公司摊薄每股收益为0.22元，在已披露的同业公司中排名第45，较去年同报告期摊薄每股收益增加0.13 元，同比较去年同期上涨144.44%。 2025年8月27日，美诺华(603538.SH)发布2025年中报。 公司营业总收入为6.77亿元，在已披露的同业公司中排名第46，较去年同报告期营业总收入增加6944.93 万元，实现2年连续上涨，同比较去年同期上涨11.42%。归母净利润为4905.52万元，较去年同报告期归 母净利润增加3011.27万元，同比较去年同期上涨158.97%。经营活动现金净流入为-693.32万元，较去年 同报告期经营活动现金净流入增加3753.38万元，实现2年连续上涨。 公司最新资产负债率为49.71%，较上季度资产负债率减少0.34个百分点，较去年同期资产负债率减少 1.64个百分点。 公司最新毛利率为32.45%，较上季度毛利率增加1.04个百分点，较去年同期毛利率增加2.94个百分点。 最新ROE为2.18%，较去年同期ROE增加1.29个百分点。 公司最新总资产周转率为0.15次，较去年同期总资产周转率增加0.01次，实现2年连续上涨，同比较去年 同期上涨7.07%。最 ...

1.4本半年度报告未经审计。 公司代码：603538 公司简称：美诺华（维权） 转债代码：113618 转债简称：美诺转债 第一节 重要提示 1.1本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到http://www.sse.com.cn/网站仔细阅读半年度报告全文。 1.2本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、完整 性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 1.3公司全体董事出席董事会会议。 1.5董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 第二节 公司基本情况 2.1公司简介 ■ 2.2主要财务数据 单位：元 币种：人民币 ■ 2.3前10名股东持股情况表 单位: 股 ■ 第三节 重要事项 公司应当根据重要性原则，说明报告期内公司经营情况的重大变化，以及报告期内发生的对公司经营情 况有重大影响和预计未来会有重大影响的事项 □适用 √不适用 2.4截至报告期末的优先股股东总数、前10名优先股股东情况表 □适用 √不适用 2.5控股股东或实际控制人变更情况 □适用 ...

Group 1 - The company held its 16th meeting of the 5th Board of Directors on August 26, 2025, with all 5 directors present, complying with relevant laws and regulations [3][4][6] - The meeting approved the 2025 semi-annual report and its summary, which will be disclosed on the Shanghai Stock Exchange [4][7] - The meeting also approved a special report on the storage and actual use of raised funds for the first half of 2025, which will be disclosed on the Shanghai Stock Exchange [7][8] Group 2 - The Board approved a proposal to abolish the Supervisory Board and amend the Articles of Association, transferring the powers of the Supervisory Board to the Audit Committee of the Board [9][10] - This proposal requires approval from the shareholders' meeting [11][27] - The Board also approved the revision and formulation of certain management systems, with some requiring shareholder approval [12][14] Group 3 - The company announced the date and details for the 2025 First Extraordinary General Meeting of Shareholders, scheduled for September 11, 2025 [31][33] - The meeting will adopt a combination of on-site and online voting methods [33][34] - Shareholders must register to attend the meeting, with specific registration details provided [39][40] Group 4 - The company reported on the actual use of raised funds, indicating that the total amount raised from the issuance of convertible bonds was approximately RMB 520 million, with a net amount of about RMB 512.7 million after expenses [45][46] - As of June 30, 2025, the company has implemented various projects funded by these raised funds, including a project for the production of pharmaceutical raw materials [49][50] - The company has established a management system for raised funds, ensuring compliance with relevant regulations [46][47]

宁波美诺华药业股份有限公司 关联交易管理办法 第一章 总 则 第一条 为进一步加强宁波美诺华药业股份有限公司（以下简称"公司"） 关联交易管理，明确管理职责和分工，维护公司股东和债权人的合法利益，特别 是中小投资者的合法权益，保证公司与关联人之间订立的关联交易合同符合公平、 公开、公允的原则，根据《中华人民共和国公司法》（以下简称《公司法》）《中 华人民共和国证券法》《上市公司治理准则》《上海证券交易所股票上市规则》 （以下简称《股票上市规则》）、《上海证券交易所上市公司自律监管指引第5 号——交易与关联交易》等法律法规和《宁波美诺华药业股份有限公司章程》 （以 下简称《公司章程》）的相关规定，特制订本制度。 第二条 公司应当保证关联交易的合法性、必要性、合理性和公允性，保持 公司的独立性，不得利用关联交易调节财务指标，损害公司利益。交易各方不得 隐瞒关联关系或者采取其他手段，规避公司的关联交易审议程序和信息披露义务。 第二章 关联交易和关联人 第三条 公司的关联交易，是指公司或者其控股子公司与公司关联人之间发 生的转移资源或者义务的事项，包括但不限于下列交易： 第四条 公司的关联人包括关联法人（或者其他组织 ...

宁波美诺华药业股份有限公司 累积投票制实施细则 第一章 总 则 第一条 为维护中小股东的利益，规范公司法人治理结构，规范公司选举董 事行为，根据《上海证券交易所股票上市规则》《上市公司治理准则》和《宁波 美诺华药业股份有限公司章程》（以下简称"《公司章程》"），并结合公司具 体情况制定本细则。 第二条 本细则所称累积投票制主要适用于董事的选举，即：在选举两个以 上的董事席位时，股东拥有的投票权等于该股东持有股份数与待定董事总人数的 乘积。股东既可以用所有的投票权集中投票选举一位候选董事，也可以分散投票 数位候选董事，董事一般由获得投票数较多者当选。 第三条 本实施细则所称的"董事"包括独立董事和非独立董事。由职工代 表担任的董事由公司职工民主选举产生或更换，不适用于本实施细则的相关规定。 第四条 公司董事会、独立董事、符合条件的股东可以向公司股东征集其在 股东会上的投票权，征集人应在委托权限范围内,代表股东投票选举董事,详细规 定另行制定。 第五条 公司通过累积投票制选举产生的董事，其任期不实施交错任期制， 即届中因缺额而补选的董事任期为本届余任期限，不跨届任职。 第二章 累积投票制的投票原则 第六条 股东会 ...

宁波美诺华药业股份有限公司 《中华人民共和国证券法》 《上海证券交易所股票上市规则》等法律法规、规范性文件，以及《宁波美诺华 药业股份有限公司章程》 （以下简称《公司章程》）的有关规定，结合公司的实际 情况，制定本制度。 第二条 本制度适用于公司及公司的控股子公司（包括全资子公司及其他控 股子公司，下同）。公司为他人提供担保，包括为其控股子公司或者合并报表范 围内其他主体提供担保，适用本制度的规定。 第三条 本制度所称对外担保是指公司以自有资产或信用为其它单位或个人 提供的保证、资产抵押、质押以及其它担保事项，包括公司对子公司的担保。具 体种类包括借款担保、银行开立信用证和银行承兑汇票担保、开具保函的担保等。 第四条 公司控股子公司对于向公司合并报表范围之外的主体提供担保的， 应视同公司提供担保。其对外担保应执行本制度，并应获得公司董事会批准。公 司子公司在其董事会或股东会做出决议后应及时通知公司董事会秘书。 对外担保管理制度 第一章 总 则 第一条 为了规范宁波美诺华药业股份有限公司（以下简称"公司"）的对外 担保行为，防范对外担保风险，确保公司资产安全和保护投资者的合法权益，根 据《中华人民共和国民法典》 ...

《上海证券交易所股票上市规则》 宁波美诺华药业股份有限公司 董事会议事规则 第一章 总 则 第一条 为明确宁波美诺华药业股份有限公司（以下简称"公司"）董事会的职责权限， 规范董事会组织、董事行为及操作规则，充分发挥董事会的作用，督促董事正确行使其权利 并履行其义务, 完善公司的法人治理结构，根据《中华人民共和国公司法》、 《中华人民共和 国证券法》、 （以下简称《股票上市规则》）等法律法规、规 范性文件，以及《宁波美诺华药业股份有限公司章程》 （以下简称《公司章程》 ）的有关规定， 制定本规则，作为董事及董事会运作的行为准则。 第二章 董事会的组成和职权 第二条 公司董事会由 5 名董事组成，独立董事 2 名，设董事长 1 名。董事长和副董事 长由董事会以全体董事的过半数选举产生。 第三条 董事可以由高级管理人员兼任，但兼任高级管理人员职务的董事以及由职工代 表担任的董事，总计不得超过公司董事总数的 1/2。 第四条 董事会行使下列职权： （一）召集股东会，并向股东会报告工作； （二）执行股东会的决议； （三）决定公司的经营计划和投资方案； （四）制订公司的利润分配方案和弥补亏损方案； （五）制订公司增加或 ...

Core Viewpoint - The company has established a comprehensive system for managing public opinion to enhance its ability to respond to various types of public sentiment and protect investor rights [2][3]. Group 1: Definition and Classification of Public Sentiment - Public sentiment includes negative media coverage, rumors that may harm the company, information affecting investor decisions, and other events impacting stock prices [2]. - Public sentiment is classified into major public sentiment, which significantly affects the company's image and operations, and general public sentiment, which is less impactful [2]. Group 2: Organizational Structure and Responsibilities - The company has formed a Public Sentiment Management Working Group led by the chairman, with responsibilities including decision-making and coordinating responses to public sentiment [3][4]. - The Securities Affairs Department is responsible for monitoring and reporting significant public sentiment, ensuring timely communication with the board [4]. Group 3: Principles and Measures for Handling Public Sentiment - The company emphasizes quick response, coordinated communication, proactive engagement, and systematic operations in managing public sentiment [5][6]. - For major public sentiment, the working group will investigate the situation, communicate with media, and ensure transparent communication with investors [6]. Group 4: Reporting and Handling Procedures - The reporting process involves immediate notification to the board secretary upon detection of public sentiment, especially for major issues [5][6]. - General public sentiment can be handled flexibly by the board secretary and the Securities Affairs Department based on specific circumstances [6]. Group 5: Accountability and Legal Considerations - Employees and related personnel have confidentiality obligations regarding public sentiment information, with potential penalties for breaches [7]. - The company reserves the right to pursue legal action against media spreading false information that harms its reputation [7].

Core Points - The company is named Ningbo Meinuohua Pharmaceutical Co., Ltd., established as a joint-stock company in accordance with the Company Law of the People's Republic of China [1][2] - The registered capital of the company is RMB 219,822,861 [1] - The company was approved by the China Securities Regulatory Commission to issue 30 million shares to the public in 2017 and was listed on the Shanghai Stock Exchange [1][3] Chapter Summaries Chapter 1: General Provisions - The purpose of the articles is to protect the legal rights of the company, shareholders, employees, and creditors [1] - The company is a permanent joint-stock company [1] - The legal representative of the company is the chairman of the board [1] Chapter 2: Business Objectives and Scope - The company's business objective is to create a leading large-scale biopharmaceutical group with independent intellectual property rights and core competitiveness [1] - The business scope includes the production of tablets and capsules, sales of pharmaceutical raw materials, and research and development of pharmaceutical intermediates [1] Chapter 3: Shares - The total number of shares is 219,822,861, all of which are ordinary shares [3] - The company can increase registered capital through various methods, including issuing shares to unspecified objects or existing shareholders [3][4] - The company is prohibited from repurchasing its own shares except under specific circumstances [4] Chapter 4: Shareholders and Shareholder Meetings - Shareholders have rights to dividends, voting, and supervision of the company's operations [6] - The company must hold an annual general meeting within six months after the end of the previous fiscal year [10] - Shareholder meetings can be called by the board of directors or by shareholders holding more than 10% of the shares [12] Chapter 5: Proposals and Notifications for Shareholder Meetings - Proposals must fall within the authority of the shareholder meeting and be clearly defined [13] - Shareholders can propose temporary motions 10 days before the meeting [13] Chapter 6: Voting and Resolutions of Shareholder Meetings - Ordinary resolutions require a simple majority, while special resolutions require two-thirds of the votes [18] - The company must disclose the results of voting on significant matters affecting minority investors [19]

General Principles - The company establishes an external investment management system to enhance the management of external investments, standardize investment behavior, and improve investment efficiency [1][3] - The system outlines principles, decision-making procedures, approval authority, management, and post-investment evaluation [1][3] Investment Definition - External investment refers to profit-oriented or value-preserving investments made by the company, its controlling subsidiaries, or entities under its actual control, including equity investments in newly established enterprises, capital increases, and asset acquisitions [1][4] Investment Management Principles - Investments must align with national laws, regulations, and industry policies [3][4] - The investment management should adhere to the company's development strategy and not adversely affect its main business [4][5] - The principle of prioritizing benefits and controlling investment risks must be followed [4][5] Decision-Making and Approval Process - The company's board of directors and shareholders' meeting serve as the decision-making bodies for external investments, with no other departments or individuals authorized to make such decisions [3][4] - The board's strategic committee is responsible for pre-reviewing major investments and monitoring project execution [3][4] Approval Authority - Major investment matters require board approval and must be submitted to the shareholders' meeting if they meet specific thresholds, such as asset totals exceeding 50% of the company's audited total assets or profits exceeding 50% of the last audited net profit [5][6] - Investments that meet certain criteria, such as involving 10% of total assets or net assets, require board approval [6][7] Post-Investment Management - The company must strengthen post-investment management to ensure asset preservation and value increase [10][11] - Investment disposal processes must follow established approval procedures, and the company should ensure timely accounting treatment of investment disposals [10][11] Documentation and Compliance - All relevant documents, including meeting minutes and investment contracts, must be archived for future reference [11][12] - The system will take effect upon approval by the shareholders' meeting and will be interpreted by the board of directors [12]